We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastic Particles and Infusion Therapy — Evidence, Implications, and Unanswered Questions
AI summary Read the abstract
Researchers highlighted microplastic exposure via medical infusion devices and pharmaceutical containers as an underappreciated but significant route of human exposure, reviewing current evidence on particle-body interactions and identifying gaps between emerging clinical research and existing industry testing standards and regulations.
The growing accumulation of plastic waste, including microscopic particles in the environment, is an alarming development. It has long been recognised that these particles can enter the human body. Recent studies focus on environmental sources of these particles. This article highlights a less frequently discussed, but significant, route of exposure: the infusion of particles via medical devices and pharmaceutical containers. One possible reason for this is the assumption that infusion devices are inherently safe due to strict regulations and rigorous testing. Nonetheless, advances in clinical research and the development of specialised test methods have yet to be fully integrated into current industry standards. This paper reviews the current understanding of microscopic plastic particles, with emphasis on their interaction with the human body, applied test methods and limitations. It further contrasts these insights with existing regulations. Finally, it identifies key areas for future interdisciplinary research in biomedicine, engineering, and public health.
More Papers Like This
Microplastic Particles and Infusion Therapy — Evidence, Implications, and Unanswered Questions
AI summary Read the abstract
Researchers reviewed evidence that medical infusion devices and pharmaceutical containers release microscopic plastic particles directly into patients' bloodstreams, identifying a significant but underexamined exposure route and calling for updated industry standards and interdisciplinary research to assess clinical risks.
Reports of Microplastic in Human Blood
AI summary Read the abstract
Researchers reviewed evidence for microplastic particles in human blood, examining the blood compartment as a key exposure route and biomonitoring target. The findings highlight growing concern about systemic plastic particle circulation and the need for standardized detection methods to assess human health risk.
Microplastics in Human Health
AI summary Read the abstract
Researchers reviewed the detection of microplastics across freshwater, marine, and terrestrial environments and synthesized emerging evidence on their health effects in humans. The paper examines how particle characteristics — origin, shape, and polymer type — influence toxicological outcomes and bioavailability.
Unveiling the impact of microplastics: a perspective on size, shape, and composition in human health
AI summary Read the abstract
This review synthesizes how microplastic size, shape, and polymer composition influence toxicity across human organs, noting that smaller and irregularly shaped particles penetrate tissues more deeply, induce greater oxidative stress, and pose heightened risks. Understanding these physical parameters is essential for accurately assessing health risks from the microplastics routinely found in human blood, lung tissue, and the gastrointestinal tract.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.